HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Online-Only Appendix All Versions of this Article: dc06-2389v1 30/9/2314    most recent Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xu, P. Search for Related Content PubMed PubMed Citation Articles by Xu, P. Social Bookmarking                What's this?

The Role of Insulin Resistance in Predicting the Progression to Type 1 Diabetes

¹ Pediatrics, University of South Florida, Tampa, Florida;
² Benaroya Research Institute at Virginia Mason, Seattle, WA;
³ Veterans Affairs Puget Sound, University of Washington, Seattle, WA;
⁴ Diabetes Care 28: 1068-1076, 2005

jpkrischer{at}epi.usf.edu

ABSTRACT

Objective --: To determine if insulin resistance is a risk factor for developing Type 1 Diabetes in autoantibody poisitve first-degree relatives of diabetic family members.

Research Design and Methods --: Subjects (n=186) who had a projected 25% to 50% risk for diabetes and subjects (n=170) who had a projected >50% risk for Type 1 Diabetes in five years were followed as part of the DPT-1 study to clinical diabetes onset or the end of the study. We assessed insulin secretion with first phase insulin response (FPIR), and insulin resistance with HOMA-R from the IVGTT. The median follow-up was 4.3 years for moderate risk subjects and 3.7 years for high risk subjects.

Results --: 53 subjects in the moderate risk group and 70 subjects in the high risk group developed Type 1 Diabetes during the follow-up period. After adjusted for confounders by using multivariate analysis, HOMA-R and FPIR/HOMA-R ratio were significantly associated with Type 1 Diabetes in both risk groups. In the moderate risk population, the hazard ratio of HOMA-R was 2.70(95% CI: 1.45-5.06) and the hazard ratio of FPIR/HOMA-R was 0.32 (95% CI: 0.18-0.57). In the high risk population, the hazard ratio of HOMA-R was 1.83 (95% CI: 1.19-2.82) and FPIR/HOMA-R was 0.56(95% CI: 0.40-0.78).

Conclusions --: There is clear evidence of the association between insulin resistance and the progression to Type 1 Diabetes. The combination of FPIR and HOMA-R could be used as a better metabolic indicator for Type 1 Diabetes risk in prediction and suggest possible intervention strategies for diabetes prevention.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. M. Lamb, X. Yin, K. Barriga, M. R. Hoffman, A. E. Baron, G. S. Eisenbarth, M. Rewers, and J. M. Norris Dietary Glycemic Index, Development of Islet Autoimmunity, and Subsequent Progression to Type 1 Diabetes in Young Children J. Clin. Endocrinol. Metab., October 1, 2008; 93(10): 3936 - 3942. [Abstract] [Full Text] [PDF]

				J. M. Sosenko, J. P. Krischer, J. P. Palmer, J. Mahon, C. Cowie, C. J. Greenbaum, D. Cuthbertson, J. M. Lachin, J. S. Skyler, and the Diabetes Prevention Trial-Type 1 Study Group A Risk Score for Type 1 Diabetes Derived From Autoantibody-Positive Participants in the Diabetes Prevention Trial-Type 1 Diabetes Care, March 1, 2008; 31(3): 528 - 533. [Abstract] [Full Text] [PDF]